October 21, 2009 - Osta's cancer technology published in a prestigious journal (.pdf)
August 18, 2009 - Prostate Cancer Canada grants award to Osta's principal investigator (.pdf)
March 24, 2009 - Osta announces promising human prostate tissue biopsy pathology results (.pdf)
October 21, 2008 - Osta receives funding from Institute for the Study of Aging (.pdf)
June 19, 2008 - Osta Reports Significantly Enhanced Anti-Metastatic Activity Of Its New Experimental Drug For Prostate Cancer (.pdf)
March 11, 2008 - Osta's new experimental drug for prostate cancer shows promise as an anti-metastatic drug (.pdf)
February 26, 2008 - OSTA BIOTECHNOLOGIES INC. appoints Dr. Walter Szarek to its scientific advisory board (.pdf)
January 22, 2008 - OSTA BIOTECHNOLOGIES INC. announces promising pro-clinical results on a new experimental drug for prostate cancer (.pdf)
Dec 17, 2007 - OSTA BIOTECHNOLOGIES INC. announces closing of private placement (.pdf)
October 15, 2007 - OSTA BIOTECHNOLOGIES INC. (“Osta”, TSXV: OBI) today announced breakthrough results on its lead anti-cancer therapeutic agent OB-24 in pre-clinical studies on human cancer cells implanted in mice (.pdf)
June 20, 2007 - OSTA BIOTECHNOLOGIES INC. annual and special meeting (.pdf)
June 14, 2007 - OSTA BIOTECHNOLOGIES INC. announces promising pre-clinical results on a new cancer drug (.pdf)May 28, 2007 - OSTA BIOTECHNOLOGIES INC. receives Notice of Allowance from the Canadian Intellectual Property Office on key PEX patent (.pdf)
April 17, 2007 - OSTA BIOTECHNOLOGIES INC. announces first closing of private placement (.pdf)
March 27, 2007 – OSTA BIOTECHNOLOGIES INC. announces the appointment of Dr. Gerald Batist to its Clinical Advisory Board (.pdf)
March 6, 2007– OSTA BIOTECHNOLOGIES INC. announces the appointment of Dr.
February 21, 2007 – OSTA BIOTECHNOLOGIES INC. announces $4.0 million private placement led by Notre-Dame Capital Inc. (.pdf)Moulay Alaoui-Jamali to its Scientific Advisory Board. (.pdf)
Archives